Search Results

Agricola

Record details

Variant-adapted COVID-19 booster vaccines.

• Authors : Krammer, Florian; Ellebedy, Ali H.

Subjects: BOOSTER vaccines; SARS-CoV-2; COVID-19 vaccines

• Source: Science. 10/13/2023, Vol. 382 Issue 6667, p157-159. 3p. 1 Diagram.

Record details

Predictors of willingness to receive updated 2023-2024 COVID-19 booster vaccines among a convenience sample in Minnesota.

• Authors : Ricke IJ; Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA. Electronic address: .; Spaulding AB

• Source: Vaccine [Vaccine] 2024 Apr 18. Date of Electronic Publication: 2024 Apr 18.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Third time's a harm? Cardiac risk of SARS-CoV-2 mRNA booster vaccines in younger men.

• Authors : Cooper LT; Department of Cardiovascular Medicine, Mayo Clinic in Florida, 4500 San Pablo, Jacksonville, FL 32224, USA.; Hasin T

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Male

• Source: European heart journal [Eur Heart J] 2024 Apr 14; Vol. 45 (15), pp. 1336-1338.Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults: A systematic review and meta -regression analysis.

• Authors : Nealon J; World Health Organization Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.; Mefsin YM

• Source: Vaccine: X [Vaccine X] 2024 Feb 02; Vol. 17, pp. 100451. Date of Electronic Publication: 2024 Feb 02 (Print Publication: 2024).Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101748769 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-1362

Record details

Joel Kim Booster.

• Authors : Cho, Margaret (AUTHOR); Dickstein, Leslie (AUTHOR); Espada, Mariah (AUTHOR)

Subjects: BOOSTER vaccines; ASIAN AmericansKIM Booster, Joel, 1988-

• Source: TIME Magazine. 10/10/2022, Vol. 2022 Issue 13/14, p75-76. 2p. 1 Color Photograph.

Record details

RESPIRATORY ILLNESSES are back as holiday season nears.

• Authors : WOLFF, TERESA

Subjects: *HEALTH facilities; *RESPIRATORY syncytial virus infections; *INFLUENZA

• Source: Wyoming Business Report. 2023 Healthy Wyoming, p4-5. 2p.

Record details

Reports Outline Vaccines Study Findings from Universitas Muslim Indonesia (K-Nearest Neighbors Analysis for Public Sentiment towards Implementation of Booster Vaccines in Indonesia).

• Source: Vaccine Weekly. 2024, pages. 796

Record details

New Findings on COVID-19 from Novavax Inc. Summarized (Immunogenicity and Safety of Heterologous Omicron Ba.1 and Bivalent Sars-cov-2 Recombinant Spike Protein Booster Vaccines: a Phase 3 Randomized Clinical Trial).

• Source: Medical Letter on the CDC & FDA. 2024, pages. 368

Record details

University of Hong Kong Researchers Focus on COVID-19 (Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults: A systematic review and meta-regression analysis).

• Source: Vaccine Weekly. 2024, pages. 762

Record details

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.

• Authors : Routhu, Nanda Kishore; Stampfer, Samuel David; Lai, Lilin

Subjects: BOOSTER vaccines; SARS-CoV-2 Omicron variant; COVID-19 vaccinesNOVAVAX Inc.

• Source: Science Immunology; Oct2023, Vol. 8 Issue 88, p1-15, 15p

Record details

Reports Outline COVID-19 Study Results from Chiang Mai University (Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand).

• Source: Vaccine Weekly. 2023, pages. 351

Record details

Immunogenicity, clinical efficacy and safety of additional second COVID-19 booster vaccines against Omicron and its subvariants: A systematic review.

• Authors : Chenchula S; All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.; Chandra MB

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use; Humans SARS-CoV-2 variants

• Source: Reviews in medical virology [Rev Med Virol] 2024 Jan; Vol. 34 (1), pp. e2515.Publisher: Wiley Country of Publication: England NLM ID: 9112448 Publication Model: Print Cited Medium: Internet ISSN: 1099-1654 (Electronic)

Record details

Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand.

• Authors : Intawong K; Faculty of Public Health, Chiang Mai University, Chiang Mai, Thailand.; Chariyalertsak S

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

• Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 15; Vol. 19 (3), pp. 2291882. Date of Electronic Publication: 2023 Dec 11.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand.

• Authors : Intawong K; Faculty of Public Health, Chiang Mai University, Chiang Mai, Thailand.; Chariyalertsak S

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

• Source: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi [J Microbiol Immunol Infect] 2023 Dec; Vol. 56 (6), pp. 1178-1186. Date of Electronic Publication: Publisher: published by Elsevier for the Taiwan Society of Microbiology Country of Publication: England NLM ID: 100956211 Publication Model: Print-Electronic

Record details

The superiority of bivalent over monovalent booster vaccines.

• Authors : Arbel R; Community Medical Services Division, Clalit Health Services, Tel Aviv, Israel; Maximising Health Outcomes Research Lab, Sapir College, Sderot, Israel. Electronic address: .

Subjects: Vaccines* ; Vaccines, Combined* ; Immunization, Secondary*

• Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Dec; Vol. 23 (12), pp. 1324-1325. Date of Electronic Publication: 2023 Aug 02.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial.

• Authors : Bennett C; Novavax, Inc., Gaithersburg, MD, 20878, USA.; Rivers EJ

• Source: The Journal of infectious diseases [J Infect Dis] 2023 Nov 16. Date of Electronic Publication: 2023 Nov 16.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet

Record details

New Findings on COVID-19 from Novavax Inc. Summarized (Immunogenicity and Safety of Heterologous Omicron Ba.1 and Bivalent Sars-cov-2 Recombinant Spike Protein Booster Vaccines: a Phase 3 Randomized Clinical Trial)

• Source: Medical Letter on the CDC & FDA. March 10, 2024, 368

Record details

University of Hong Kong Researchers Focus on COVID-19 (Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults: A systematic review and meta-regression analysis)

• Source: Vaccine Weekly. March 6, 2024, 762

Record details

What to Know About the New COVID-19 Booster Shots Planned for Next Month.

• Authors : Smith-Schoenwalder, Cecelia (AUTHOR)

Subjects: *COVID-19 vaccines; *SARS-CoV-2; *COVID-19

• Source: U.S. News & World Report - The Report. 9/1/2023, pC9-C11. 3p. 1 Color Photograph.

Record details

Researchers from Lahore College for Women University Report Recent Findings in COVID-19 (Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis).

• Source: Vaccine Weekly. 2023, pages. 649

Record details

U.S. Clinical Trial: Institute of Tropical Medicine, Belgium Listed a New Clinical Trial to Study Safety and Immunogenicity of Ervebo and Zabdeno Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea or Ervebo Vaccine Schedules in DRC (EBO-BOOST).

• Source: Contify Life Science News. 2023.

Record details

Reports Outline COVID-19 Study Results from Chiang Mai University (Role of booster vaccines and hybrid immunity against severe COVID-19 outcomes during BA.5 omicron predominance in Thailand)

• Source: Vaccine Weekly. December 27, 2023, 351

Record details

DATASET ON YOUNG PEOPLE'S INTENTION TOWARDS COVID-19 BOOSTER VACCINES IN MALAYSIA.

• Authors : Arham, Ahmad Firdhaus; Mustapa, Muhammad Adzran Che; Hassan, Wan Zulkifli Wan

Subjects: BOOSTER vaccines; COVID-19 vaccines; COVID-19MALAYSIAASTRAZENECA PLC

• Source: Journal of Pharmaceutical Negative Results; 2022 Special Issue, Vol. 13, p863-869, 7p

Record details

Preliminary nerve block for intradermal facial skin booster injections.

• Authors : Yi, Kyu‐Ho^1,2 (AUTHOR)

Subjects: *NERVE block; *BOOSTER vaccines; *INJECTIONS

• Source: Journal of Cosmetic Dermatology. Apr2024, Vol. 23 Issue 4, p1229-1232. 4p.

Record details